Literature DB >> 4907517

Treatment of persistent phenothiazine-induced oral dyskinesia.

P A Roxburgh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4907517     DOI: 10.1192/bjp.116.532.277

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  8 in total

Review 1.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

2.  Severe persistent chorea with phenothiazine therapy: report of a case.

Authors:  K Singer; M Wong
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

3.  Persistent tardive dyskinesia.

Authors:  S G Carruthers
Journal:  Br Med J       Date:  1971-09-04

4.  Thiopropazate hydrochloride in persistent dyskinesia.

Authors:  K Singer; M N Cheng
Journal:  Br Med J       Date:  1971-10-02

5.  Six month evaluation of thiopropazate hydrochloride in tardive dyskinesia.

Authors:  J S Smith; L G Kiloh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-06       Impact factor: 10.154

6.  Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose.

Authors:  M F Egan; T M Hyde; J E Kleinman; R J Wyatt
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

7.  Clinical aspects of dyskinesia.

Authors:  J Ananth
Journal:  Indian J Psychiatry       Date:  1980-07       Impact factor: 1.759

Review 8.  Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.

Authors:  Hanna Bergman; John Rathbone; Vivek Agarwal; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.